Showing results (11-20 of 284) with videos related to

Sort By:
Pageof 29
Circulation|April 19, 2000
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy menP M Ridker, N Rifai, M J Stampfer, et al.
Circulation|July 21, 1999
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) InvestigatorsP M Ridker, N Rifai, M A Pfeffer, et al.
Circulation|May 10, 2000
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarctionP M Ridker, N Rifai, M Pfeffer, et al.
JAMA|July 24, 2001
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitusA D Pradhan, J E Manson, N Rifai, et al.
Circulation|August 18, 1999
Hormone replacement therapy and increased plasma concentration of C-reactive proteinP M Ridker, C H Hennekens, N Rifai, et al.
Clinical Chemistry|March 10, 2001
Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adultsI S Ockene, C E Matthews, N Rifai, et al.
Clinical Chemistry|March 10, 2001
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjectsH K Meier-Ewert, P M Ridker, N Rifai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 9, 1999
Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatationL E Rohde, L H Arroyo, N Rifai, et al.
The New England Journal of Medicine|June 30, 2001
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary eventsP M Ridker, N Rifai, M Clearfield, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2001
Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal womenD M Herrington, K B Brosnihan, B E Pusser, et al.
Pageof 29